Shares of Inovio Pharmaceuticals Inc. INO advanced 1.90% to $1.61 Friday, on what proved to be an all-around positive trading ...

Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Inovio Pharmaceuticals Inc. closed 89.14% below its 52-week high of $13.44, which the company reached on May 16th.

The stock market has seen some wild swings in reaction to announcements of new tariffs by the Trump administration. Here’s a glance at how some of Georgia’s top companies are doing in the stock market ...

Desjardins analyst A. Leon anticipates that the company will earn $0.01 per share for the quarter. Desjardins also issued ...

Inovio Pharmaceuticals, Inc.’s INO share price has surged by 10.67%, which has investors questioning if this is right time to sell.

Inovio Pharmaceuticals (INO) has been beaten down lately with too much selling pressure. While the stock has lost 11.4% over ...

Explore Unicycive Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for UNCY. Why Limbach Holdings Shares Are Trading Lower By Around 15%?

INO stock opened at $1.92 on Friday. Inovio Pharmaceuticals has a 52 week low of $1.74 and a 52 week high of $14.75. The firm’s fifty day moving average is $2.04 and its 200 day moving average ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...